Jessica Alber
Overview
Explore the profile of Jessica Alber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravichandran S, Snyder P, Alber J, Murchison C, Chaby L, Jeromin A, et al.
Alzheimers Res Ther
. 2025 Jan;
17(1):19.
PMID: 39794837
Background: The potential diagnostic value of plasma amyloidogenic beta residue 42/40 ratio (Aβ42/Aβ40 ratio), neurofilament light (NfL), tau phosphorylated at threonine-181 (p-tau181), and threonine-217 (p-tau217) has been extensively discussed in...
2.
Dubois A, Sergio J, Mozdbar S, Price A, Stradtman M, Thompson L, et al.
Front Aging Neurosci
. 2024 Dec;
16:1465812.
PMID: 39679257
Introduction: Subjective visual impairment (VI) is related to cognition in cognitively unimpaired (CU) older adults, mild cognitive impairment (MCI) patients, and Alzheimer's disease (AD) patients. The utility of subjective VI...
3.
Leclerc H, Lee A, Kunicki Z, Alber J
J Alzheimers Dis
. 2024 Nov;
102(1):89-98.
PMID: 39497301
Background: Plasma biomarkers have recently emerged for the diagnosis, assessment, and disease monitoring of Alzheimer's disease (AD), but have yet to be fully validated in preclinical AD. In addition to...
4.
Ravichandran S, Snyder P, Alber J, Kenny M, Rothstein A, Brown K, et al.
Invest Ophthalmol Vis Sci
. 2024 May;
65(5):5.
PMID: 38696189
Purpose: Neuroinflammation plays a significant role in the pathology of Alzheimer's disease (AD). Mouse models of AD and postmortem biopsy of patients with AD reveal retinal glial activation comparable to...
5.
Popescu D, Lee A, Arthur E, Thompson L, Alber J
J Geriatr Psychiatry Neurol
. 2024 Mar;
37(6):482-495.
PMID: 38459948
Background: Studies have shown apolipoprotein E (APOE) genotype disclosure to be safe and well-tolerated in cognitively unimpaired (CU) older adults. This study aimed to examine the effect of the disclosure...
6.
Alber J, Bouwman F, den Haan J, Rissman R, De Groef L, Koronyo-Hamaoui M, et al.
Alzheimers Dement
. 2023 Nov;
20(1):728-740.
PMID: 37917365
There is emerging evidence that amyloid beta protein (Aβ) and tau-related lesions in the retina are associated with Alzheimer's disease (AD). Aβ and hyperphosphorylated (p)-tau deposits have been described in...
7.
Arthur E, Ravichandran S, Snyder P, Alber J, Strenger J, Bittner A, et al.
Alzheimers Res Ther
. 2023 Oct;
15(1):172.
PMID: 37828548
Background: Compared to standard neuro-diagnostic techniques, retinal biomarkers provide a probable low-cost and non-invasive alternative for early Alzheimer's disease (AD) risk screening. We have previously quantified the periarteriole and perivenule...
8.
Mozdbar S, Alber J, Aryal S, Johnson L, Moroz A, Rashik M, et al.
Alzheimers Dement (Amst)
. 2022 Nov;
14(1):e12378.
PMID: 36407937
Introduction: Visual function and cognitive impairment are interrelated; however, little is known about the impact of modifying treatable vision impairment on the development of cognitive dysfunction. This study examines the...
9.
Cersonsky T, Mechery S, Thompson L, Lee A, Alber J, Sarkar I, et al.
J Neuroimaging
. 2022 Sep;
32(6):1075-1079.
PMID: 36151065
Background And Purpose: Subtle cognitive decline represents a stage of cognitive deterioration in which pathological biomarkers may be present, including early cortical atrophy and amyloid deposition. Using individual items from...
10.
Cersonsky T, Mechery S, Carper M, Thompson L, Lee A, Alber J, et al.
Neuropsychology
. 2022 May;
36(5):373-383.
PMID: 35511561
Objective: Dementia is a devastating neurological disease that may be better managed if diagnosed earlier when subclinical neurodegenerative changes are already present, including subtle cognitive decline and mild cognitive impairment....